Erfonrilimab (Anti-CTLA4 & PD-L1)
Gecertificeerd

Erfonrilimab (Anti-CTLA4 & PD-L1)

Catalog #: C00871
Maat: 1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

CAS Number

2367013-69-0

Synonyms

KN 046

SKU

C00871-1mg

Target

PD-1/PD-L1

Applications

Apoptosis

Additionnal Information

Erfonrilimab is a humanized bispecific monoclonal antibody directed against programmed cell death-1 ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. It is used to treat solid tumors and exhibits promising efficacy in advanced non-small cell lung cancer (NSCLC) patients who had experienced failure or intolerance to prior platinum-based chemotherapy. MW: 107.44 KD.

Storage Conditions

-80°C (avoid freeze-thaw cycles)

Beschrijving

Erfonrilimab (Anti-CTLA4 & PD-L1) Beschikbaar in 1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamErfonrilimab (Anti-CTLA4 & PD-L1)
Categorie
Beschikbare grootte1 mg
CatalogusnummerC00871